0001209191-15-008483.txt : 20150202
0001209191-15-008483.hdr.sgml : 20150202
20150202211131
ACCESSION NUMBER: 0001209191-15-008483
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150129
FILED AS OF DATE: 20150202
DATE AS OF CHANGE: 20150202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYLAN INC.
CENTRAL INDEX KEY: 0000069499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251211621
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 MYLAN BOULEVARD
CITY: CANONSBURG
STATE: PA
ZIP: 15317
BUSINESS PHONE: 724-514-1800
MAIL ADDRESS:
STREET 1: 1000 MYLAN BOULEVARD
CITY: CANONSBURG
STATE: PA
ZIP: 15317
FORMER COMPANY:
FORMER CONFORMED NAME: MYLAN LABORATORIES INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: FRM CORP
DATE OF NAME CHANGE: 19711003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mauro Anthony
CENTRAL INDEX KEY: 0001534275
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09114
FILM NUMBER: 15568986
MAIL ADDRESS:
STREET 1: 1500 CORPORATE DRIVE
CITY: CANONSBURG
STATE: PA
ZIP: 15317
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-01-29
0
0000069499
MYLAN INC.
MYL
0001534275
Mauro Anthony
1000 MYLAN BLVD
CANONSBURG
PA
15317
0
1
0
0
President, North America
Common Stock
2015-01-29
4
M
0
12150
0.00
A
50399
D
Common Stock
2015-01-29
4
A
0
45086
0.00
A
95485
D
Common Stock
2015-01-29
4
F
0
25404
54.885
D
70081
D
Common Stock
2015-01-29
4
M
0
7300
23.44
A
77381
D
Common Stock
2015-01-29
4
M
0
16792
30.90
A
94173
D
Common Stock
2015-01-29
4
F
0
16237
54.885
D
77936
D
Common Stock
5574
I
By 401(k) Plan
Restricted Stock Units
0.00
2015-01-29
4
M
0
12150
0.00
D
2015-01-29
Common Stock
12150
0
D
Employee Stock Option - Right to Buy
23.44
2015-01-29
4
M
0
7300
0.00
D
2015-01-29
2022-02-22
Common Stock
7300
7398
D
Employee Stock Option - Right to Buy
30.90
2015-01-29
4
M
0
16792
0.00
D
2015-01-29
2023-03-06
Common Stock
16792
13251
D
Represents acquisition of shares of Mylan common stock upon vesting of RSUs.
Represents acquisition of shares of Mylan common stock upon vesting of PRSUs. Each PRSU represents the right to receive shares of Mylan common stock. The PRSUs were granted on February 22, 2012, March 6, 2013 and March 5, 2014.
Represents withholding of shares of Mylan common stock for the tax liability associated with the vesting of RSUs and PRSUs.
Represents acquisition of Mylan common stock upon exercise of stock options granted on February 22, 2012.
Represents acquisition of Mylan common stock upon exercise of stock options granted on March 6, 2013.
Represents withholding of shares of Mylan common stock to satisfy the exercise price and tax liability associated with the exercise of stock options granted on February 22, 2012 and March 6, 2013.
Each RSU represents the right to receive one share of Mylan common stock. The RSUs were granted on February 22, 2012, March 6, 2013 and March 5, 2014.
The transactions described on this Form 4 are described in the proxy statement filed by Mylan Inc. ("Mylan") on December 24, 2014 and the Form 8-K filed by Mylan on November 5, 2014. In connection with the proposed acquisition (the "Transaction") by a new public company organized in the Netherlands of both Mylan and Abbott Laboratories' non-U.S. developed markets specialty and branded generics business, Mylan's Board of Directors determined, effective November 4, 2014, that the vesting of all unvested stock options, restricted stock units ("RSUs"), and performance restricted stock units ("PRSUs") granted to directors and executive officers as part of Mylan's ordinary course annual equity compensation program (other than incentive stock options and the options granted in 2014) would be accelerated prior to the Transaction.
/s/ Bradley L. Wideman, by power of attorney
2015-02-02